Pfeffer, M A, Claggett, B, Diaz, R, Dickstein, K, Gerstein, H C, Køber, L V, Lawson, F C, Ping, L, Wei, X, Lewis, E F, Maggioni, A P, McMurray, J J V, Probstfield, J L, Riddle, M C, Solomon, S D, Tardif, J-C & ELIXA Investigators 2015, ' Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome ', The New England Journal of Medicine, vol. 373, no. 23, pp. 2247-2257 . https://doi.org/10.1056/NEJMoa1509225 Pfeffer, M A, Claggett, B, Diaz, R, Dickstein, K, Gerstein, H C, Køber, L V, Lawson, F C, Ping, L, Wei, X, Lewis, E F, Maggioni, A P, McMurray, J J V, Probstfield, J L, Riddle, M C, Solomon, S D, Tardif, J-C, ELIXA Investigators & Rungby, J 2015, ' Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome ' The New England Journal of Medicine, vol. 373, no. 23, pp. 2247-57 . https://doi.org/10.1056/NEJMoa1509225
New England Journal of Medicine Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827 Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE